Vimarsana
Biggest News Aggregation in the World

Wenming Chen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Wenming Chen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Wenming Chen Today - Breaking & Trending Today

CARsgen Announces NDA Acceptance of BCMA CAR T Zevor-cel (CT053) by China NMPA - Vimarsana News

CARsgen Announces NDA Acceptance of BCMA CAR T Zevor-cel (CT053) by China NMPA

SHANGHAI, Oct. 18, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell th...

Police: Glen Burnie spa one of growing number of businesses being investigated in county - Vimarsana News

Police: Glen Burnie spa one of growing number of businesses being investigated in county

A Glen Burnie spa in which two people were arrested on prostitution charges late last week is part of a growing number of such businesses in the county, an Anne Arundel police spokesman said on Tuesday.

Antengene Announces Addition of Multiple XPOVIO® Treatment Regimens for Myeloma and Lymphoma in 2022 CSCO Guidelines - Vimarsana News

Antengene Announces Addition of Multiple XPOVIO® Treatment Regimens for Myeloma and Lymphoma in 2022 CSCO Guidelines

/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...

CARsgen Presents Updated Research Results on BCMA CAR T-cell Product (CT053) at 2021 ASH Annual Meeting - Vimarsana News

CARsgen Presents Updated Research Results on BCMA CAR T-cell Product (CT053) at 2021 ASH Annual Meeting

/PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of...

Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guidelines - Vimarsana News

Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guidelines

Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guidelines News provided by Share this article Share this article SHANGHAI and HONG KONG, May 5, 2021 /PRNewswire/ -- AntengeneĀ Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, today announced that the Chinese Society of Clinical Oncology (CSCO), the most prominent organization in oncology in China, added multiple selinexor re...